spacer

It is difficult to say what is impossible,
for the dreams of yesterday
are the hopes of today
and the reality
of tomorrow.


Robert H. Goddard

spacer





The Acid Maltase Deficiency Association, A M D A, was formed to assist in funding
research and to promote public
awareness of Acid Maltase Deficiency,
also known as Pompe's Disease.

Updated February 02, 2007



spacer 2006 AMDA/IPA Patient Conference Report

spacer Acid Maltase Deficiency-- A Brief Summary 

spacer AMDA's Advisory Board

spacer AMDA's Review of Geeta Anand's "The Cure"

spacer 2004-2005 Initiatives for Pompe's Disease

spacer 2005 AGSD-UK Conference Report

spacer Listing of All Clinical Studies for Pompe's Disease--(Type in "Pompe")

  • Information on Late-onset screening study now available

spacer IPA Patient Questionnaire (Still in progress)

  • Article on the Results of the IPA/Erasmus Patient Questionnaire

  • Second Article on the Results of the IPA/Erasmus Patient Questionnaire

  • Third Article on the Results of the IPA/Erasmus Patient Questionnaire

spacer Physician's Guide to Pompe's Disease--Free Pamphlet from NORD

spacer AMDA's Pompe's Disease Communication Program

spacer AMDA's Pompe Mentoring Program

spacer Respiratory Support Information

  • Flying with a Ventilator in the United States

spacer Pompe Center of the Erasmus Medical Center Rotterdam, The Netherlands-- (Contains mutation database)

spacer Meet the Patients--(Story of a Patient in the Clinical Trials)

spacer AMDA Patient Registry

spacer Research Publications on Pompe's Disease (new article added)

spacer Research Developments

  • Scientific Board Formed
  • Research Highlights
  • AMDA Projects
  • AMDA Patient Conferences -- 2001 and 2006

spacer Clinical Trials

  • General Information
  • January 1999--Sophia Children's Hospital/Erasmus University, The Netherlands
    Clinical Trials Begin--Pharming Group N.V.
  • June 1999--Duke University Medical Center-U.S.A.
    Clinical Trials Begin--Synpac Pharmaceuticals Limited
  • March 2001--Genzyme/Pharming/Synpac--Joint Venture Formed--Technology Purchased
     2000-2001-Clinical Trials--Exclusive Interview with Genzyme
  • May 2001--Novazyme Pharmaceutical, Inc., U.S.A.
     Clinical Trials Planned--Exclusive Interview with Novazyme

  • August 2001--Article on Transgenic Enzyme Replacement Therapy

  • August 2001--Genzyme/Novazyme Merger

  • October 2001-- Genzyme Acquires Pharming Manufacturing Facility

  • April 2002-- Genzyme Press Release

  • July 2002--Genzyme Begins Phase Out of Enzyme Produced in Milk of Transgenic Rabbits

  • March 2003-- AMDA's Response to Article in MDA's "Quest"

  • March 2003-- Genzyme Enrolling Patients in New Clinical Trial (Study 1702)

  • May 2003-- Genzyme Enrolling Patients in New Clinical Trial (Study 1602)

  • January 2004 --AMDA Newsletter Detailing Genzyme Initiatives in 2004

  • April 2004 -- Suspension of Late-Onset Expanded Access Program

  • August 2004 -- Joint IPA/Genzyme Statement announcing the new status of the Expanded Access Programs

  • December 2004 -- December 2004 Update of Genzyme's Pompe Project

  • December 2004 -- Genzyme Files for European Approval of Myozyme for Treatment of Pompe Disease

  • March 2005 -- March 2005 Update of Genzyme's Pompe Project

  • April 2005 -- Genzyme Reports Interim Results from Pivotal Study of Myozyme

  • July 2005 -- July 2005 Update of Genzyme's Pompe Project

  • July 2005 -- Genzyme Files for FDA Approval of Myozyme for Treatment of Pompe Disease

  • September 2005 -- September 2005 Update of Genzyme's Pompe Program

  • January 2006 -- Genzyme Provides Update on U.S. Marketing Application for Myozyme

  • April 2006 -- European Commission Approves Genzyme's Myozyme

  • April 2006 -- FDA Approves Genzyme's Myozyme

  • June 2006 -- Myozyme's Label available for patients to review

  • January 2007 -- January 2007 Update from Genzyme on the LOTS trial (new)

spacer IPA--International Pompe Association

  • IPA News

  • First IPA Conference--July 1999

  • IPA Board Meeting--February 2002

  • Letter from IPA Chairman--February 2002

  • Letter from Vice President of Genzyme--March 9, 2002

  • IPA/Genzyme Meeting--April 16-17, 2002

  • IPA/Genzyme News--September 24, 2002

  • IPA Patient Questionnaire--November 2002 (Still in Progress) 

  • IPA/Genzyme News--December 2002

  • IPA Conference --October 30-November 1, 2003

  • Summary of 2004 International Pompe Association Conference

  • The IPA has developed a Pompe Connections Brochure--October 2005

  • Summary of the 2005 AFM-IPA Conference available

  • Letter from IPA and Genzyme concerning LOTS

spacer Memorials

spacer Other Webs of Interest

spacer AMDA Guest Book

 

To contact the AMDA

spacer

Thank you, Donna, for all of your help!

AMDA, Acid Maltase Deficiency Association, Inc. 1997
P.O. Box 700248 San Antonio, Texas 78270-0248
Phone: (210) 494-6144 
Fax: (210) 490-7161 

gipoco.com is neither affiliated with the authors of this page nor responsible for its contents. This is a safe-cache copy of the original web site.